Medicament Production Aquitaine Pharm International

Aquitaine Pharm International (API) is a specialized Contract Development and Manufacturing Organization (CDMO) and a subsidiary of the Pierre Fabre Group. Based in Idron, France, API focuses on the development and aseptic production of complex injectable drugs, with a core expertise in cytotoxic and highly potent compounds (HPAPI) primarily for oncology. The company provides end-to-end services including formulation development, clinical trial supply, and commercial-scale manufacturing, featuring advanced lyophilization and liquid filling capabilities. As a key player in the Pierre Fabre CDMO network, API serves a global clientele of pharmaceutical and biotechnology companies.